Pterygium is a degenerative change of the conjunctiva and cornea that appears as a triangular formation that originates from the conjunctiva and grows onto the surface of the cornea. This condition is usually painless, but can lead to vision impairment and aesthetic defects. Pterygium often occurs due to exposure to ultraviolet radiation, dust, wind, and other factors that contribute to chronic irritation of the conjunctiva. Pterygium can be either unilateral or bilateral, and in some cases requires surgical intervention for treatment, especially when it begins to interfere with vision or cause discomfort.
History of the disease and interesting historical facts
Pterygium was described in medical literature more than 2,500 years ago. A description of this condition can be found in the works of Hippocrates, who mentioned vision pathologies associated with various external factors. Famous ophthalmologists such as Aristotle and Galileo also paid attention to this disease, trying to explain its nature. In the Middle Ages, attention to pterygium increased significantly, which is associated with the development of ophthalmology as a scientific discipline. An interesting feature is that in some cultures this disease was considered a "victory of the sun" and was treated with folk medicine. In the 20th century, modern surgical treatment methods appeared that allow you to effectively cope with pterygium, which significantly improved the quality of life of patients.
Epidemiology
The epidemiology of pterygium varies depending on the geographical location, climate conditions and exposure to harmful environmental factors. According to modern epidemiological studies, the prevalence of pterygium ranges from 2% to 30% among the population of different regions of the world. The highest incidence is observed in countries with a tropical climate and high exposure to sunlight, such as Australia and Southeast Asian countries. Statistics show that the disease is more common in people working outdoors, such as farmers and builders, as well as in people over 40 years of age, which is associated with age-related changes in eye tissue.
Genetic predisposition to this disease
To date, genetic predisposition to pterygium is the subject of active study, but specific genetic markers have not been definitively established. According to researchers, some mutational changes in genes responsible for collagen metabolism and protective functions of the conjunctiva may contribute to the development of this pathology. In particular, candidate mutations in genes associated with the DNA repair system and inflammatory processes have been identified. It is also noted that some familial cases of pterygium suggest the presence of hereditary factors, although specific mechanisms still require further study.
Risk factors for the development of this disease
In the development of pterygoid hymen, several key risk factors should be taken into account, among which are:
- Exposure to ultraviolet radiation: Prolonged exposure to the sun without protective eyewear increases the risk of pterygium.
- Chronic irritants: dust, wind and chemicals that can damage the conjunctiva.
- Age: the disease is more often diagnosed in older people, which is associated with age-related changes.
- Gender: Men are more likely to develop pterygium than women.
- Outdoor work: Occupational risks for people working in the sun significantly increase the likelihood of developing the disease.
Diagnosis of this disease
Diagnosis of pterygium is made based on clinical examination and patient history. The main symptoms that should lead to suspicion of pterygium include:
- Visual impairment.
- Feeling of a foreign body in the eye.
- Redness and irritation of the conjunctiva.
- Aesthetic discomfort.
For a final diagnosis, doctors may conduct the following tests:
- Impression tests to assess tear production.
- Ultrasound examination to determine the depth of the lesion.
- Microscopic examination using a slit lamp.
- Differential diagnosis with other ophthalmological diseases such as conjunctivitis, conjunctival cyst or tumor.
Treatment
Treatment for alar hymen varies depending on the severity of the clinical picture and symptoms. Treatment options include:
- Observation: if there are no complaints and minor changes, monitoring the condition may be sufficient.
- Pharmacological treatment: use of anti-inflammatory and moisturizing eye drops.
- Surgical treatment: resection of pterygium and possible transplantation to prevent recurrence.
- Laser therapy: In some cases, this may be used to remove the growth.
List of medications used to treat this disease
Among the medications used to treat pterygium are:
- Anti-inflammatory drops (eg, diclofenac).
- Lubricating drops (eg artificial tears).
- Corticosteroids to reduce inflammation (eg, prednisolone).
- Medicines to slow the growth of connective tissue (eg, mitomycin C, used after surgery).
Disease monitoring
Monitoring the patient's condition after pterygium diagnosis includes regular follow-up examinations with an ophthalmologist. The main stages of monitoring are as follows:
- Evaluation of the condition of the cornea and conjunctiva every 6-12 months.
- Discussion of possible changes and recommendations for prevention.
- Prognosis: in most cases, with timely treatment, visual function is restored, but relapses are possible.
- Complications: Possible complications following pterygium removal include recurrence of the growth and infection.
Age-related features of the disease
Pterygoid hymen is more common in people over 40 years of age, but can also develop in younger people, especially if they have certain risk factors. In older patients, pterygoid hymen may be accompanied by other eye problems, such as cataracts or glaucoma. In younger people, the disease may develop more aggressively and lead to more severe consequences, which is explained by their increased susceptibility to harmful environmental influences. It is important to consider age-related changes in eye tissues and individual patient characteristics when developing a treatment plan.
Questions and Answers
- What factors contribute to the development of pterygoid hymen? The main factors are long-term exposure to ultraviolet radiation, chronic irritants and age-related changes.
- How is pterygium diagnosed? Diagnosis includes a doctor's examination, analysis of complaints, and the use of special research methods such as a slit lamp.
- What treatment is indicated for pterygium? Treatment can be conservative, including drops, or surgical with removal of the formation.
- Can pterygoid hymen be prevented? Yes, it is recommended to avoid prolonged unprotected sun exposure and minimize exposure to chemicals.
- What is the prognosis for treating pterygoid hymen? The prognosis is usually good, but there is a risk of relapse, so regular monitoring is necessary.
